CN1177855C - 糖类衍生物 - Google Patents
糖类衍生物 Download PDFInfo
- Publication number
- CN1177855C CN1177855C CNB981224148A CN98122414A CN1177855C CN 1177855 C CN1177855 C CN 1177855C CN B981224148 A CNB981224148 A CN B981224148A CN 98122414 A CN98122414 A CN 98122414A CN 1177855 C CN1177855 C CN 1177855C
- Authority
- CN
- China
- Prior art keywords
- compound
- solution
- methyl
- tlc
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 CC(OCC([C@@](C1C=O)O)O[C@@](*)C1C=O)=O Chemical compound CC(OCC([C@@](C1C=O)O)O[C@@](*)C1C=O)=O 0.000 description 13
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Oncology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97203613 | 1997-11-19 | ||
EP97203613.1 | 1997-11-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1222524A CN1222524A (zh) | 1999-07-14 |
CN1177855C true CN1177855C (zh) | 2004-12-01 |
Family
ID=8228942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB981224148A Expired - Fee Related CN1177855C (zh) | 1997-11-19 | 1998-11-18 | 糖类衍生物 |
Country Status (34)
Country | Link |
---|---|
US (1) | US6174863B1 (cs) |
EP (1) | EP1032579B1 (cs) |
JP (1) | JP4364959B2 (cs) |
KR (1) | KR100518497B1 (cs) |
CN (1) | CN1177855C (cs) |
AR (1) | AR017640A1 (cs) |
AT (1) | ATE239030T1 (cs) |
AU (1) | AU746959B2 (cs) |
BR (1) | BRPI9804699B1 (cs) |
CA (1) | CA2253113C (cs) |
CO (1) | CO4990974A1 (cs) |
CZ (1) | CZ293639B6 (cs) |
DE (1) | DE69814140T2 (cs) |
DK (1) | DK1032579T3 (cs) |
EE (1) | EE04348B1 (cs) |
ES (1) | ES2198081T3 (cs) |
HK (1) | HK1028406A1 (cs) |
HU (1) | HU226685B1 (cs) |
ID (1) | ID21287A (cs) |
IL (1) | IL126893A (cs) |
IS (1) | IS2527B (cs) |
NO (1) | NO310723B1 (cs) |
NZ (1) | NZ332834A (cs) |
PE (1) | PE134799A1 (cs) |
PL (1) | PL188229B1 (cs) |
PT (1) | PT1032579E (cs) |
RU (1) | RU2210573C2 (cs) |
SG (1) | SG72889A1 (cs) |
SK (1) | SK284134B6 (cs) |
TR (1) | TR199802372A2 (cs) |
TW (1) | TW448180B (cs) |
UA (1) | UA49089C2 (cs) |
WO (1) | WO1999025720A1 (cs) |
ZA (1) | ZA9810559B (cs) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI289566B (en) | 1999-12-07 | 2007-11-11 | N.V.Organon | Antithrombotic compound |
EP1353556A4 (en) * | 2001-01-23 | 2009-09-09 | Massachusetts Inst Technology | SYNTHESIS OF HEPARIN AND OTHER GLYCOSAMINOGLYCANS IN SOLID PHASE AND SOLUTION PHASE |
AU2003302238A1 (en) | 2002-12-03 | 2004-06-23 | Axys Pharmaceuticals, Inc. | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
CN1317287C (zh) * | 2003-04-18 | 2007-05-23 | 山东大学 | 一种多硫酸寡糖及其制备方法 |
MXPA06010049A (es) * | 2004-03-04 | 2007-04-10 | Progen Ind Ltd | Derivados de oligosacaridos sulfatados. |
CN103333264B (zh) | 2008-05-30 | 2016-06-08 | 动量制药公司 | 糖结构以及制造和使用此类结构的方法 |
CA2735983A1 (en) * | 2008-09-10 | 2010-03-18 | Transpharma Medical Ltd. | Transdermal delivery of oligosaccharides |
CN104245718B (zh) | 2009-07-31 | 2016-11-09 | 可靠生物医药公司 | 制备磺达肝素钠的方法及其合成中使用的中间体 |
US8420790B2 (en) | 2009-10-30 | 2013-04-16 | Reliable Biopharmaceutical Corporation | Efficient and scalable process for the manufacture of Fondaparinux sodium |
WO2012172104A1 (en) * | 2011-06-17 | 2012-12-20 | Endotis Pharma | Synthetic pentasaccharides having short half-life and high activity |
EP2578594A1 (en) | 2011-10-04 | 2013-04-10 | Sanofi | Process of preparation of L-iduronic acid comprising a decarboxylation/intramolecular cyclisation tandem reaction |
US9873712B2 (en) | 2014-10-03 | 2018-01-23 | Amphastar Pharmaceuticals, Inc. | Method of purifying idraparinux sodium |
CN109134555B (zh) * | 2017-06-15 | 2021-09-28 | 南京正大天晴制药有限公司 | 抗凝血的五糖类化合物及其制备方法和医药用途 |
CN109134553B (zh) * | 2017-06-15 | 2021-09-28 | 南京正大天晴制药有限公司 | 抗凝血的五糖类化合物及其制备方法和医药用途 |
CN109134554B (zh) * | 2017-06-15 | 2021-09-28 | 南京正大天晴制药有限公司 | 抗凝血的五糖类化合物及其制备方法和医药用途 |
WO2021043631A1 (en) | 2019-09-02 | 2021-03-11 | Hepoligo Solutions Aps | Intermediates useful for preparing iduronic acid containing di- and polysaccharides |
WO2021211441A1 (en) * | 2020-04-13 | 2021-10-21 | The Board Of Regents Of The University Of Oklahoma | Modified sugar polymers with low anticoagulant activity and therapeutic activity |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0300099A1 (en) * | 1987-07-20 | 1989-01-25 | Akzo N.V. | New pentasaccharides |
ES2060284T3 (es) * | 1990-04-23 | 1994-11-16 | Sanofi Elf | Un procedimiento para la preparacion de un derivado de carbohidrato que comprende una unidad de trisacarido. |
IL102758A (en) * | 1991-08-23 | 1997-03-18 | Akzo Nv | Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them |
-
1998
- 1998-11-04 IL IL12689398A patent/IL126893A/xx not_active IP Right Cessation
- 1998-11-09 CA CA002253113A patent/CA2253113C/en not_active Expired - Fee Related
- 1998-11-16 KR KR10-1998-0049021A patent/KR100518497B1/ko not_active IP Right Cessation
- 1998-11-16 WO PCT/EP1998/007518 patent/WO1999025720A1/en active IP Right Grant
- 1998-11-16 DE DE69814140T patent/DE69814140T2/de not_active Expired - Lifetime
- 1998-11-16 EP EP98958248A patent/EP1032579B1/en not_active Expired - Lifetime
- 1998-11-16 SK SK736-2000A patent/SK284134B6/sk not_active IP Right Cessation
- 1998-11-16 DK DK98958248T patent/DK1032579T3/da active
- 1998-11-16 PT PT98958248T patent/PT1032579E/pt unknown
- 1998-11-16 ES ES98958248T patent/ES2198081T3/es not_active Expired - Lifetime
- 1998-11-16 AT AT98958248T patent/ATE239030T1/de active
- 1998-11-16 EE EEP200000301A patent/EE04348B1/xx unknown
- 1998-11-16 UA UA2000052804A patent/UA49089C2/uk unknown
- 1998-11-17 NZ NZ332834A patent/NZ332834A/xx not_active IP Right Cessation
- 1998-11-18 HU HU9802663A patent/HU226685B1/hu not_active IP Right Cessation
- 1998-11-18 BR BRPI9804699A patent/BRPI9804699B1/pt not_active IP Right Cessation
- 1998-11-18 US US09/193,901 patent/US6174863B1/en not_active Expired - Lifetime
- 1998-11-18 JP JP32768298A patent/JP4364959B2/ja not_active Expired - Fee Related
- 1998-11-18 CN CNB981224148A patent/CN1177855C/zh not_active Expired - Fee Related
- 1998-11-18 AU AU93242/98A patent/AU746959B2/en not_active Ceased
- 1998-11-18 NO NO19985365A patent/NO310723B1/no not_active IP Right Cessation
- 1998-11-18 SG SG1998004851A patent/SG72889A1/en unknown
- 1998-11-18 ZA ZA9810559A patent/ZA9810559B/xx unknown
- 1998-11-18 RU RU98120933/04A patent/RU2210573C2/ru active
- 1998-11-18 ID IDP981506A patent/ID21287A/id unknown
- 1998-11-18 PE PE1998001123A patent/PE134799A1/es not_active IP Right Cessation
- 1998-11-19 AR ARP980105862A patent/AR017640A1/es active IP Right Grant
- 1998-11-19 TR TR1998/02372A patent/TR199802372A2/xx unknown
- 1998-11-19 CZ CZ19983761A patent/CZ293639B6/cs not_active IP Right Cessation
- 1998-11-19 PL PL98329789A patent/PL188229B1/pl unknown
- 1998-11-19 CO CO98068215A patent/CO4990974A1/es unknown
- 1998-11-23 TW TW087119398A patent/TW448180B/zh not_active IP Right Cessation
-
2000
- 2000-05-09 IS IS5485A patent/IS2527B/is unknown
- 2000-12-07 HK HK00107848A patent/HK1028406A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1177855C (zh) | 糖类衍生物 | |
CN1024557C (zh) | 透明质酸配合物的制备方法 | |
CN1200003C (zh) | 合成多糖、其制备方法以及含有它们的药物组合物 | |
CN1094942C (zh) | 苯基乙基酮衍生物及其制备方法 | |
CN1009096B (zh) | 一种具有抗血栓形成,溶解纤维蛋白,消炎活性的解聚的硫酸氨基己糖聚糖,其制方法以及有关药品组合物 | |
CN1023803C (zh) | 制备新的α-葡糖甘酶抑制剂的方法 | |
CN1235914C (zh) | 含有至少一个具有生物素或生物素衍生物共价键的具有抗血栓形成活性的多糖 | |
CN1798771A (zh) | 由肝素衍生的多糖混合物、其制备方法以及含有它们的药物组合物 | |
CN1165550C (zh) | 合成多糖和含有它们的药物组合物以及其用途 | |
CN1040539C (zh) | 3-脱氧低聚糖,其制备方法和含有它们的药物组合物 | |
CN1266427A (zh) | 新的脒基衍生物及其作为凝血酶抑制剂的用途 | |
CN1172948C (zh) | 新的五糖及其制备方法和含有它们的药物组合物 | |
CN1261450C (zh) | 抗血栓形成化合物 | |
CN1295251C (zh) | 由k5多糖衍生具有高抗血栓形成活性的糖胺聚糖及其制备方法 | |
CN1058016C (zh) | 氨基糖硫酸酯及其药学上可用的盐、其制备方法及其用途 | |
CN1243759C (zh) | 聚亚烷基氧改性的磷脂及其制备方法 | |
CN101039963A (zh) | 生物素化十六糖,它们的制备方法及其用途 | |
CN1371391A (zh) | 抑制凝血相关凝血因子的肝素成分 | |
CN1195767C (zh) | 抗血栓形成化合物 | |
CN1176644A (zh) | 路易斯x衍生物及其制备方法 | |
CN1819833A (zh) | 促进hgf产生的含肝素类寡糖的药剂 | |
CN1343217A (zh) | 新的脒基苄基胺衍生物及其作为凝血酶抑制剂的用途 | |
CN1918143A (zh) | 连接子化合物、配体络合物和它们的制备方法 | |
CN86106534A (zh) | 碳环嘌呤核苷,其制备及用途 | |
CN1675249A (zh) | N-酰基-(表)k5-胺-o-硫酸盐衍生物及其产品的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041201 Termination date: 20171118 |
|
CF01 | Termination of patent right due to non-payment of annual fee |